Literature DB >> 3802109

Cardiovascular effects of apomorphine in humans: evidence for peripheral mechanisms.

O J Rascol, J L Montastruc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3802109     DOI： 10.1097/00002826-198612000-00010

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  3 in total

1.  Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.

Authors:  U Sabatini; O Rascol; P Celsis; G Houin; A Rascol; J P Marc-Vergnes; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

2.  A study of tolerance to apomorphine.

Authors:  J L Montastruc; M E Llau; J M Senard; M A Tran; O Rascol; P Montastruc
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs.

Authors:  J L Montastruc; M Lapeyre-Mestre; M E Llau; J M Senard; O Rascol; P Montastruc
Journal:  Clin Auton Res       Date:  1994-12       Impact factor: 4.435
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.